CBP LA Schedules New Trade Forum on Changes to FDA/CBP Refusal and Redelivery Processes
CBP Los Angeles scheduled another trade forum to discuss planned updates to CBP's and the Food and Drug Administration's refusal/redelivery process, it said in a public notice. Topics will include FDA exams and entry review, exports and destructions, the new CBP/FDA joint redelivery process, and CBP's refund and cancellation policy, said the notice. Email documents@brokerpower.com for a copy of the public notice.
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
The presentation will be handled by representatives of the FDA and CBP, said the notice. The presentation will begin at 9:30 a.m. Oct. 16 at the Long Beach Administrative Building, 925 Harbor Plaza, Long Beach, Calif., 90802. Questions should be directed to Harout Barsoumian at (562) 366-5710.